Trastuzumab deruxtecan (T-DXd)
优赫得 (Enhertu)
An antibody-drug conjugate: a HER2 antibody carrying a chemo payload straight into cancer cells. One of the most effective breast-cancer drugs ever tested.
At a glance
China price
Verified pricing is not currently available.
NRDL (national insurance)
Entered NRDL in a recent adjustment (partial indications).
Regulatory status
NMPA approved (2023)
What this meansSupported by a credible secondary source but not yet independently confirmed against a primary source.
SourceNo independent source on file.
NotesApproval status from public regulatory reporting.
International comparison
US list ~USD 2,500+ per 100mg
What this meansReported information that has not yet been independently confirmed.
SourceNo independent source on file.
NotesReported comparison, not independently verified.
What it treats
HER2-positive and HER2-low breast cancer after prior therapy; HER2+ gastric cancer.
How it is accessed in China
- Hospitals
- DTP pharmacies
Sources & verification
No independent source is currently on file. We have not independently verified this information.
Reader discussion
Public comments about Trastuzumab deruxtecan (T-DXd). Discussion is not medical advice, and a comment is not an endorsement or a verified fact. Open the full forum.